Zoetis
$79.62
2331
-$0.42-0.52% 20:00 Today
+$0.00+0%21:19After hours
Statistics
Day High
80
Day Low
78.88
52W High
148.3
52W Low
68.77
Volume
3,030,912
Avg. Volume
5,214,837
Mkt Cap
32.9B
P/E Ratio
12.39
Dividend Yield
2.68%
Dividend
2.13
Upcoming
Dividends
2.68%Dividend Yield
Sep 2026
$0.53
Jun 2026
$0.53
Mar 2026
$0.53
Dec 2025
$0.50
Sep 2025
$0.50
10Y Growth
18.97%
5Y Growth
17.08%
3Y Growth
12.96%
1Y Growth
8.18%
Earnings
Nov 5Expected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.4
1.56
1.71
1.87
Expected EPS
1.505656
Actual EPS
N/A
Financials
28.23%Profit Margin
Profitable9.47BRevenue
2.67BNet Income
Analyst Ratings
$91.33Average Price Target
The highest estimate is 115.00.
From 14 ratings within the last 6 months. This is not an investment recommendation.
From 14 ratings within the last 6 months. This is not an investment recommendation.
Buy 43%
Hold 57%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ZTS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Elanco Animal Health
ELAN
Mkt Cap11.06B
Idexx Laboratories
IDXX
Mkt Cap40.84B
Merck
MRK
Mkt Cap356.01B
Phibro Animal Health
PAHC
Mkt Cap1.51B
About
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Show More
CEO
Kristin C. Peck
Employees
14500
Country
United States
ISIN
US98978V1035
WKN
000A1KBYX
Listings
1 Comment
ZłotySmok
long term is a great company to own at the right valuation of course which is where it’s at right now. The moat is more resliant and durable compared to traditional human pharma companies. the companion segment will be a growth driver for year to come especially with OA.
0
FAQs
What is Zoetis stock price today?▼
The current price of ZTS is $79.62 USD — it has decreased by -0.52% in the past 24 hours. Watch Zoetis stock price performance more closely on the chart.
What is Zoetis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Zoetis stocks are traded under the ticker ZTS.
Is Zoetis stock price growing?▼
ZTS stock has risen by +5.75% compared to the previous week, the month change is a +11.62% rise, over the last year Zoetis has showed a -45.5% decrease.
What is Zoetis market cap?▼
Today Zoetis has the market capitalization of 32.9B
When is the next Zoetis earnings date?▼
Zoetis is going to release the next earnings report on November 5, 2026.
What were Zoetis earnings last quarter?▼
ZTS earnings for the last quarter are 1.87 USD per share, whereas the estimation was 1.85 USD resulting in a +0.95% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Zoetis revenue for the last year?▼
Zoetis revenue for the last year amounts to 9.47B USD.
What is Zoetis net income for the last year?▼
ZTS net income for the last year is 2.67B USD.
Does Zoetis pay dividends?▼
Yes, ZTS dividends are paid quarterly. The last dividend per share was 0.53 . As of today, Dividend Yield (FWD)% is 2.68%.
How many employees does Zoetis have?▼
As of October 21, 2026, the company has 14,500 employees.
In which sector is Zoetis located?▼
Zoetis operates in the Health & Wellness sector.
When did Zoetis complete a stock split?▼
Zoetis has not had any recent stock splits.
Where is Zoetis headquartered?▼
Zoetis is headquartered in PARSIPPANY, United States.